Kocuria rosea is predominantly regarded as a non-pathogenic commensal bacterium that resides in the oropharynx, skin, and mucous membranes without causing harm to the host in healthy individuals. However, in immunocompromised patients, it can become an opportunistic pathogen. Reports from different countries have highlighted instances where Kocuria rosea was associated with various infections.
In India, a study found that Kocuria rosea was isolated from 0.6% of urine samples taken from patients with urinary tract infections between 2015 and 2017. Additionally, a case report from China described a patient with cholecystitis caused by Kocuria rosea in 2018. These cases demonstrate that Kocuria rosea can be responsible for infections in the genitourinary and biliary systems.
Kocuria rosea has also been implicated in nosocomial infections, infections acquired within healthcare facilities. One case report from Brazil reported catheter-associated bacteremia caused by Kocuria rosea in 2019 in a patient with a history of chronic kidney disorder and hemodialysis. Moreover, a case report from Turkey described a patient with keratitis caused by Kocuria rosea in 2020, who had a history of contact lens use and corneal trauma.
Another case report from Iran also documented a patient with endocarditis caused by Kocuria rosea in 2020, who had a history of rheumatic heart disease and mitral valve replacement. These cases highlight the risk of Kocuria rosea infections in healthcare settings and the importance of infection control measures to prevent its spread. While Kocuria rosea is generally considered non-pathogenic in healthy individuals, these reported cases emphasize the significance of vigilance in monitoring and managing infections, particularly in immunocompromised patients or those with specific risk factors.
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus: Kocuria
Species: Kocuria rosea
Kocuria rosea is a gram-positive bacterium with a coccus shape; it appears as spherical or oval cells. The cells occur in the tetrad arrangement, forming groups of four cells that are typically seen together.
On culture media, isolated colonies of Kocuria rosea are smooth and pink, with a diameter of about 1.0 to 1.5 mm.
Kocuria rosea is a strict aerobe, non-motile, and does not form endospores. It possesses a capsule, a protective layer outside the cell wall.
Kocuria rosea produces a carotenoid pigment that imparts a distinctive rose color to the bacterial colonies.
Kocuria rosea is known for its unique rose color, attributed to the production of a carotenoid pigment. Carotenoids are organic compounds that serve as antioxidants and provide photoprotection to the bacterium. They play a vital role in protecting Kocuria rosea from oxidative stress and potential DNA damage caused by UV radiation. Additionally, carotenoids can influence the host’s immune response by regulating the expression of chemokines & cytokines.
In the genome of Kocuria rosea, more than 200 genes are associated with membrane transport. Membrane transporters are essential proteins that facilitate the movement of various substances across the cell membrane, regulating nutrient uptake and waste elimination.
Two well-characterized strains of Kocuria rosea are ATCC 186 and ATCC 49321. ATCC 186 is the type strain serving as the reference strain for the species. It was originally isolated from soil in 1886 and initially classified as Micrococcus roseus. However, it was later reclassified as Kocuria rosea in 1995 by Stackebrandt et al. ATCC 49321, on the other hand, was isolated from a human blood culture in 1994. These strains serve as valuable resources for research & understanding the bacterium’s characteristics.
Kocuria rosea can cause opportunistic infections in individuals with weakened immune systems or compromised barriers, such as patients with rheumatic heart disease, diabetes mellitus, chronic kidney disease, or those undergoing immunosuppressive therapy. When the host’s immune defenses are compromised, Kocuria rosea can take advantage of the opportunity to invade and proliferate in different body sites, leading to various infections.
Adherence & colonization of Kocuria rosea to host tissues or medical equipment, like catheters or contact lenses, is the first stage in pathogenesis. The ability of the bacteria to attach to these surfaces allows it to develop a niche and avoid host immune responses. Certain virulence factors in Kocuria rosea may contribute to its pathogenicity. It, for example, produces a carotenoid pigment that gives it a rose hue & may have antioxidant and photoprotective features. Furthermore, the bacteria may include membrane transporters that aid in nutrition uptake & adaptability to the host environment.
Kocuria rosea infections can trigger an inflammatory response from the host’s immune system. The activation of immune cells & pro-inflammatory cytokines production can result in tissue damage and infection-like symptoms such as redness, swelling, and discomfort. Kocuria rosea infections can cause significant problems like sepsis, abscess development, endocarditis, & organ failure in severe instances. These problems can be fatal, especially in people with pre-existing medical disorders.
The human host defenses against Kocuria rosea are not extensively studied, but certain factors influence susceptibility or resistance to this bacterium. One critical factor is the integrity of the skin, which serves as a physical barrier against microorganisms. While Kocuria rosea can colonize the skin without causing harm, it can potentially invade through wounds or skin injuries, leading to infections. Maintaining healthy skin and avoiding abrasions can contribute to preventing Kocuria rosea infections.
The host’s immune status also plays a crucial role in defense against Kocuria rosea. The immune system recognizes and eliminates foreign invaders, including bacteria. Kocuria rosea has been shown to produce carotenoids that can modulate the expression of chemokines, potentially allowing the bacterium to evade or suppress the immune response. As a result, individuals with weakened immunity due to underlying diseases or immunosuppressive treatments may be more susceptible to Kocuria rosea infections. Enhancing immune function and avoiding immunosuppressive agents can be crucial in combating Kocuria rosea infections.
Urinary tract infections (UTIs) caused by K. rosea typically present with symptoms such as a burning sensation during urination, frequent urination, cloudy or bloody urine, and lower abdominal pain. These infections can be uncomfortable and require appropriate antibiotic treatment to resolve the symptoms and prevent complications.
Cholecystitis is another manifestation of K. rosea infection, characterized by gallbladder inflammation. Patients with cholecystitis may experience severe abdominal pain, fever, nausea, vomiting, and jaundice. Prompt medical attention and treatment are crucial to manage cholecystitis effectively.
rosea can also be involved in catheter-associated bacteremia, contaminating intravenous catheters, and leading to bloodstream infections. Catheter-related infections can be severe, resulting in septic shock, organ failure, and other severe complications if not promptly addressed.
Furthermore, K. rosea is associated with endocarditis, a potentially fatal illness characterized by an infection of the heart valves. Endocarditis can cause fever, chills, excessive sweating at night, weight loss, pain in the heart, shortness of breath, & blood clot formation. Timely and aggressive treatment is crucial in managing endocarditis and preventing severe cardiac complications.
Kocuria rosea diagnosis tests can be performed using a combination of traditional laboratory identification tests & sophisticated procedures. Biochemical investigations are critical in the early identification of K. rosea. Because these bacteria’s metabolic reactions vary, tests like catalase, urease, & citrate utilization tests are done. Kocuria rosea is catalase-positive, which means it produces the catalase enzyme, which degrades hydrogen peroxide. It is also urease & citrate negative.
In addition, Kocuria rosea does not ferment mannitol and lacks coagulase enzyme production. On blood agar, they do not produce hemolysis, and initial colonies are tiny, whitish, round, raised, and convex, which might develop non-diffusible yellowish pigmentation after prolonged incubation.
Kocuria rosea typically forms isolated colonies on a circular TSA (Tryptic Soy Agar) plate, measuring around 1.0 to 1.5 mm in size. These colonies have a slightly convex appearance and a smooth texture. One of the characteristic features of Kocuria rosea colonies is their pink color, which gives them a distinct and easily recognizable appearance on the culture medium.
While standard biochemical tests can offer preliminary information, reliable identification of Kocuria rosea may necessitate the use of sophisticated techniques like as the sequencing of 16S rRNA or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectroscopy. These new approaches can provide exact identification by evaluating genetic and protein profiles. In clinical microbiology laboratories, automated identification systems such as API, VITEK, & the BD Phoenix automated microbiology system are routinely utilized. However, they may need help identifying Kocuria spp. from other bacteria, resulting in an incorrect coagulase-negative Staphylococci (CoNS) diagnosis.
In cases where advanced laboratory methods are unavailable, Kocuria can still be identified & differentiated from Staphylococci using conventional tests. Although these may not identify species, they can offer valuable preliminary information.
Special attention should be given to immunocompromised patients, who are more vulnerable to Kocuria rosea infections.
Following strict catheter care protocols can minimize the risk of catheter-associated bacteremia and infection.
Healthcare workers should receive proper training on infection control practices and be educated about preventing opportunistic infections in vulnerable patients.
Kocuria rosea is predominantly regarded as a non-pathogenic commensal bacterium that resides in the oropharynx, skin, and mucous membranes without causing harm to the host in healthy individuals. However, in immunocompromised patients, it can become an opportunistic pathogen. Reports from different countries have highlighted instances where Kocuria rosea was associated with various infections.
In India, a study found that Kocuria rosea was isolated from 0.6% of urine samples taken from patients with urinary tract infections between 2015 and 2017. Additionally, a case report from China described a patient with cholecystitis caused by Kocuria rosea in 2018. These cases demonstrate that Kocuria rosea can be responsible for infections in the genitourinary and biliary systems.
Kocuria rosea has also been implicated in nosocomial infections, infections acquired within healthcare facilities. One case report from Brazil reported catheter-associated bacteremia caused by Kocuria rosea in 2019 in a patient with a history of chronic kidney disorder and hemodialysis. Moreover, a case report from Turkey described a patient with keratitis caused by Kocuria rosea in 2020, who had a history of contact lens use and corneal trauma.
Another case report from Iran also documented a patient with endocarditis caused by Kocuria rosea in 2020, who had a history of rheumatic heart disease and mitral valve replacement. These cases highlight the risk of Kocuria rosea infections in healthcare settings and the importance of infection control measures to prevent its spread. While Kocuria rosea is generally considered non-pathogenic in healthy individuals, these reported cases emphasize the significance of vigilance in monitoring and managing infections, particularly in immunocompromised patients or those with specific risk factors.
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus: Kocuria
Species: Kocuria rosea
Kocuria rosea is a gram-positive bacterium with a coccus shape; it appears as spherical or oval cells. The cells occur in the tetrad arrangement, forming groups of four cells that are typically seen together.
On culture media, isolated colonies of Kocuria rosea are smooth and pink, with a diameter of about 1.0 to 1.5 mm.
Kocuria rosea is a strict aerobe, non-motile, and does not form endospores. It possesses a capsule, a protective layer outside the cell wall.
Kocuria rosea produces a carotenoid pigment that imparts a distinctive rose color to the bacterial colonies.
Kocuria rosea is known for its unique rose color, attributed to the production of a carotenoid pigment. Carotenoids are organic compounds that serve as antioxidants and provide photoprotection to the bacterium. They play a vital role in protecting Kocuria rosea from oxidative stress and potential DNA damage caused by UV radiation. Additionally, carotenoids can influence the host’s immune response by regulating the expression of chemokines & cytokines.
In the genome of Kocuria rosea, more than 200 genes are associated with membrane transport. Membrane transporters are essential proteins that facilitate the movement of various substances across the cell membrane, regulating nutrient uptake and waste elimination.
Two well-characterized strains of Kocuria rosea are ATCC 186 and ATCC 49321. ATCC 186 is the type strain serving as the reference strain for the species. It was originally isolated from soil in 1886 and initially classified as Micrococcus roseus. However, it was later reclassified as Kocuria rosea in 1995 by Stackebrandt et al. ATCC 49321, on the other hand, was isolated from a human blood culture in 1994. These strains serve as valuable resources for research & understanding the bacterium’s characteristics.
Kocuria rosea can cause opportunistic infections in individuals with weakened immune systems or compromised barriers, such as patients with rheumatic heart disease, diabetes mellitus, chronic kidney disease, or those undergoing immunosuppressive therapy. When the host’s immune defenses are compromised, Kocuria rosea can take advantage of the opportunity to invade and proliferate in different body sites, leading to various infections.
Adherence & colonization of Kocuria rosea to host tissues or medical equipment, like catheters or contact lenses, is the first stage in pathogenesis. The ability of the bacteria to attach to these surfaces allows it to develop a niche and avoid host immune responses. Certain virulence factors in Kocuria rosea may contribute to its pathogenicity. It, for example, produces a carotenoid pigment that gives it a rose hue & may have antioxidant and photoprotective features. Furthermore, the bacteria may include membrane transporters that aid in nutrition uptake & adaptability to the host environment.
Kocuria rosea infections can trigger an inflammatory response from the host’s immune system. The activation of immune cells & pro-inflammatory cytokines production can result in tissue damage and infection-like symptoms such as redness, swelling, and discomfort. Kocuria rosea infections can cause significant problems like sepsis, abscess development, endocarditis, & organ failure in severe instances. These problems can be fatal, especially in people with pre-existing medical disorders.
The human host defenses against Kocuria rosea are not extensively studied, but certain factors influence susceptibility or resistance to this bacterium. One critical factor is the integrity of the skin, which serves as a physical barrier against microorganisms. While Kocuria rosea can colonize the skin without causing harm, it can potentially invade through wounds or skin injuries, leading to infections. Maintaining healthy skin and avoiding abrasions can contribute to preventing Kocuria rosea infections.
The host’s immune status also plays a crucial role in defense against Kocuria rosea. The immune system recognizes and eliminates foreign invaders, including bacteria. Kocuria rosea has been shown to produce carotenoids that can modulate the expression of chemokines, potentially allowing the bacterium to evade or suppress the immune response. As a result, individuals with weakened immunity due to underlying diseases or immunosuppressive treatments may be more susceptible to Kocuria rosea infections. Enhancing immune function and avoiding immunosuppressive agents can be crucial in combating Kocuria rosea infections.
Urinary tract infections (UTIs) caused by K. rosea typically present with symptoms such as a burning sensation during urination, frequent urination, cloudy or bloody urine, and lower abdominal pain. These infections can be uncomfortable and require appropriate antibiotic treatment to resolve the symptoms and prevent complications.
Cholecystitis is another manifestation of K. rosea infection, characterized by gallbladder inflammation. Patients with cholecystitis may experience severe abdominal pain, fever, nausea, vomiting, and jaundice. Prompt medical attention and treatment are crucial to manage cholecystitis effectively.
rosea can also be involved in catheter-associated bacteremia, contaminating intravenous catheters, and leading to bloodstream infections. Catheter-related infections can be severe, resulting in septic shock, organ failure, and other severe complications if not promptly addressed.
Furthermore, K. rosea is associated with endocarditis, a potentially fatal illness characterized by an infection of the heart valves. Endocarditis can cause fever, chills, excessive sweating at night, weight loss, pain in the heart, shortness of breath, & blood clot formation. Timely and aggressive treatment is crucial in managing endocarditis and preventing severe cardiac complications.
Kocuria rosea diagnosis tests can be performed using a combination of traditional laboratory identification tests & sophisticated procedures. Biochemical investigations are critical in the early identification of K. rosea. Because these bacteria’s metabolic reactions vary, tests like catalase, urease, & citrate utilization tests are done. Kocuria rosea is catalase-positive, which means it produces the catalase enzyme, which degrades hydrogen peroxide. It is also urease & citrate negative.
In addition, Kocuria rosea does not ferment mannitol and lacks coagulase enzyme production. On blood agar, they do not produce hemolysis, and initial colonies are tiny, whitish, round, raised, and convex, which might develop non-diffusible yellowish pigmentation after prolonged incubation.
Kocuria rosea typically forms isolated colonies on a circular TSA (Tryptic Soy Agar) plate, measuring around 1.0 to 1.5 mm in size. These colonies have a slightly convex appearance and a smooth texture. One of the characteristic features of Kocuria rosea colonies is their pink color, which gives them a distinct and easily recognizable appearance on the culture medium.
While standard biochemical tests can offer preliminary information, reliable identification of Kocuria rosea may necessitate the use of sophisticated techniques like as the sequencing of 16S rRNA or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectroscopy. These new approaches can provide exact identification by evaluating genetic and protein profiles. In clinical microbiology laboratories, automated identification systems such as API, VITEK, & the BD Phoenix automated microbiology system are routinely utilized. However, they may need help identifying Kocuria spp. from other bacteria, resulting in an incorrect coagulase-negative Staphylococci (CoNS) diagnosis.
In cases where advanced laboratory methods are unavailable, Kocuria can still be identified & differentiated from Staphylococci using conventional tests. Although these may not identify species, they can offer valuable preliminary information.
Special attention should be given to immunocompromised patients, who are more vulnerable to Kocuria rosea infections.
Following strict catheter care protocols can minimize the risk of catheter-associated bacteremia and infection.
Healthcare workers should receive proper training on infection control practices and be educated about preventing opportunistic infections in vulnerable patients.
Kocuria rosea is predominantly regarded as a non-pathogenic commensal bacterium that resides in the oropharynx, skin, and mucous membranes without causing harm to the host in healthy individuals. However, in immunocompromised patients, it can become an opportunistic pathogen. Reports from different countries have highlighted instances where Kocuria rosea was associated with various infections.
In India, a study found that Kocuria rosea was isolated from 0.6% of urine samples taken from patients with urinary tract infections between 2015 and 2017. Additionally, a case report from China described a patient with cholecystitis caused by Kocuria rosea in 2018. These cases demonstrate that Kocuria rosea can be responsible for infections in the genitourinary and biliary systems.
Kocuria rosea has also been implicated in nosocomial infections, infections acquired within healthcare facilities. One case report from Brazil reported catheter-associated bacteremia caused by Kocuria rosea in 2019 in a patient with a history of chronic kidney disorder and hemodialysis. Moreover, a case report from Turkey described a patient with keratitis caused by Kocuria rosea in 2020, who had a history of contact lens use and corneal trauma.
Another case report from Iran also documented a patient with endocarditis caused by Kocuria rosea in 2020, who had a history of rheumatic heart disease and mitral valve replacement. These cases highlight the risk of Kocuria rosea infections in healthcare settings and the importance of infection control measures to prevent its spread. While Kocuria rosea is generally considered non-pathogenic in healthy individuals, these reported cases emphasize the significance of vigilance in monitoring and managing infections, particularly in immunocompromised patients or those with specific risk factors.
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus: Kocuria
Species: Kocuria rosea
Kocuria rosea is a gram-positive bacterium with a coccus shape; it appears as spherical or oval cells. The cells occur in the tetrad arrangement, forming groups of four cells that are typically seen together.
On culture media, isolated colonies of Kocuria rosea are smooth and pink, with a diameter of about 1.0 to 1.5 mm.
Kocuria rosea is a strict aerobe, non-motile, and does not form endospores. It possesses a capsule, a protective layer outside the cell wall.
Kocuria rosea produces a carotenoid pigment that imparts a distinctive rose color to the bacterial colonies.
Kocuria rosea is known for its unique rose color, attributed to the production of a carotenoid pigment. Carotenoids are organic compounds that serve as antioxidants and provide photoprotection to the bacterium. They play a vital role in protecting Kocuria rosea from oxidative stress and potential DNA damage caused by UV radiation. Additionally, carotenoids can influence the host’s immune response by regulating the expression of chemokines & cytokines.
In the genome of Kocuria rosea, more than 200 genes are associated with membrane transport. Membrane transporters are essential proteins that facilitate the movement of various substances across the cell membrane, regulating nutrient uptake and waste elimination.
Two well-characterized strains of Kocuria rosea are ATCC 186 and ATCC 49321. ATCC 186 is the type strain serving as the reference strain for the species. It was originally isolated from soil in 1886 and initially classified as Micrococcus roseus. However, it was later reclassified as Kocuria rosea in 1995 by Stackebrandt et al. ATCC 49321, on the other hand, was isolated from a human blood culture in 1994. These strains serve as valuable resources for research & understanding the bacterium’s characteristics.
Kocuria rosea can cause opportunistic infections in individuals with weakened immune systems or compromised barriers, such as patients with rheumatic heart disease, diabetes mellitus, chronic kidney disease, or those undergoing immunosuppressive therapy. When the host’s immune defenses are compromised, Kocuria rosea can take advantage of the opportunity to invade and proliferate in different body sites, leading to various infections.
Adherence & colonization of Kocuria rosea to host tissues or medical equipment, like catheters or contact lenses, is the first stage in pathogenesis. The ability of the bacteria to attach to these surfaces allows it to develop a niche and avoid host immune responses. Certain virulence factors in Kocuria rosea may contribute to its pathogenicity. It, for example, produces a carotenoid pigment that gives it a rose hue & may have antioxidant and photoprotective features. Furthermore, the bacteria may include membrane transporters that aid in nutrition uptake & adaptability to the host environment.
Kocuria rosea infections can trigger an inflammatory response from the host’s immune system. The activation of immune cells & pro-inflammatory cytokines production can result in tissue damage and infection-like symptoms such as redness, swelling, and discomfort. Kocuria rosea infections can cause significant problems like sepsis, abscess development, endocarditis, & organ failure in severe instances. These problems can be fatal, especially in people with pre-existing medical disorders.
The human host defenses against Kocuria rosea are not extensively studied, but certain factors influence susceptibility or resistance to this bacterium. One critical factor is the integrity of the skin, which serves as a physical barrier against microorganisms. While Kocuria rosea can colonize the skin without causing harm, it can potentially invade through wounds or skin injuries, leading to infections. Maintaining healthy skin and avoiding abrasions can contribute to preventing Kocuria rosea infections.
The host’s immune status also plays a crucial role in defense against Kocuria rosea. The immune system recognizes and eliminates foreign invaders, including bacteria. Kocuria rosea has been shown to produce carotenoids that can modulate the expression of chemokines, potentially allowing the bacterium to evade or suppress the immune response. As a result, individuals with weakened immunity due to underlying diseases or immunosuppressive treatments may be more susceptible to Kocuria rosea infections. Enhancing immune function and avoiding immunosuppressive agents can be crucial in combating Kocuria rosea infections.
Urinary tract infections (UTIs) caused by K. rosea typically present with symptoms such as a burning sensation during urination, frequent urination, cloudy or bloody urine, and lower abdominal pain. These infections can be uncomfortable and require appropriate antibiotic treatment to resolve the symptoms and prevent complications.
Cholecystitis is another manifestation of K. rosea infection, characterized by gallbladder inflammation. Patients with cholecystitis may experience severe abdominal pain, fever, nausea, vomiting, and jaundice. Prompt medical attention and treatment are crucial to manage cholecystitis effectively.
rosea can also be involved in catheter-associated bacteremia, contaminating intravenous catheters, and leading to bloodstream infections. Catheter-related infections can be severe, resulting in septic shock, organ failure, and other severe complications if not promptly addressed.
Furthermore, K. rosea is associated with endocarditis, a potentially fatal illness characterized by an infection of the heart valves. Endocarditis can cause fever, chills, excessive sweating at night, weight loss, pain in the heart, shortness of breath, & blood clot formation. Timely and aggressive treatment is crucial in managing endocarditis and preventing severe cardiac complications.
Kocuria rosea diagnosis tests can be performed using a combination of traditional laboratory identification tests & sophisticated procedures. Biochemical investigations are critical in the early identification of K. rosea. Because these bacteria’s metabolic reactions vary, tests like catalase, urease, & citrate utilization tests are done. Kocuria rosea is catalase-positive, which means it produces the catalase enzyme, which degrades hydrogen peroxide. It is also urease & citrate negative.
In addition, Kocuria rosea does not ferment mannitol and lacks coagulase enzyme production. On blood agar, they do not produce hemolysis, and initial colonies are tiny, whitish, round, raised, and convex, which might develop non-diffusible yellowish pigmentation after prolonged incubation.
Kocuria rosea typically forms isolated colonies on a circular TSA (Tryptic Soy Agar) plate, measuring around 1.0 to 1.5 mm in size. These colonies have a slightly convex appearance and a smooth texture. One of the characteristic features of Kocuria rosea colonies is their pink color, which gives them a distinct and easily recognizable appearance on the culture medium.
While standard biochemical tests can offer preliminary information, reliable identification of Kocuria rosea may necessitate the use of sophisticated techniques like as the sequencing of 16S rRNA or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectroscopy. These new approaches can provide exact identification by evaluating genetic and protein profiles. In clinical microbiology laboratories, automated identification systems such as API, VITEK, & the BD Phoenix automated microbiology system are routinely utilized. However, they may need help identifying Kocuria spp. from other bacteria, resulting in an incorrect coagulase-negative Staphylococci (CoNS) diagnosis.
In cases where advanced laboratory methods are unavailable, Kocuria can still be identified & differentiated from Staphylococci using conventional tests. Although these may not identify species, they can offer valuable preliminary information.
Special attention should be given to immunocompromised patients, who are more vulnerable to Kocuria rosea infections.
Following strict catheter care protocols can minimize the risk of catheter-associated bacteremia and infection.
Healthcare workers should receive proper training on infection control practices and be educated about preventing opportunistic infections in vulnerable patients.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
